Pancreatic Cancer Research

Journal articleEur Rev Med Pharmacol Sci2020

Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship.

Journal
Eur Rev Med Pharmacol Sci
Published
1 May 2020
Citations
13
Type
Article

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Objective To study the influences of metformin on the proliferation and apoptosis of pancreatic cancer cells and its dose-effect relationship and crucial molecular mechanism. Materials and methods With human pancreatic cancer cell line PANC-1 as the study object, different concentrations of metformin were added for intervention. … Excerpt only: this text is the publisher’s. Read it in full at the source.